Actemra: Uses, Dosage, Side Effects, MOA - Drugs.com
2023年8月22日 · Actemra (tocilizumab) is a FDA approved biological medicine that is given by intravenous infusion or injection under the skin to treat specific patients with COVID-19, rheumatoid arthritis, giant cell arteritis, scleroderma, polyarticular or systemic juvenile idiopathic arthritis, and severe cytokine release syndrome.
Subcutaneous Injections for RA | ACTEMRA® (tocilizumab)
ACTEMRA® (tocilizumab) subcutaneous injection instructions and medication guide for Rheumatoid Arthritis (RA) patients. See Full Safety and Boxed Warnings for more information.
Tocilizumab (Actemra®): Uses & Side Effects - Cleveland Clinic
Tocilizumab treats certain types of arthritis such as rheumatoid arthritis and juvenile idiopathic arthritis. Arthritis causes pain and inflammation in your joints. This medication is an injection that a healthcare provider usually gives to you in a hospital or clinic setting.
Tocilizumab (Actemra®) - Johns Hopkins Arthritis Center
Tocilizumab is commonly known as Actemra®. How do I take it? Tocilizumab is given as an injection once a week or as an IV infusion once a month. If you are on the infusion, you will have this medicine at a center where nurses will place a needle in …
Actemra: Side Effects, Cost, Dosage, and More - Healthline
2022年3月6日 · If you have rheumatoid arthritis or giant cell arteritis (GCA), you can receive Actemra via either injection or IV infusion. For the injections, you’ll likely take a dose every week or every ...
Taking ACTEMRA® (tocilizumab) SC injections
ACTEMRA changes the way your immune system works. This can make you more likely to get infections or make any current infection worse. Some people have serious infections while taking ACTEMRA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body.
before you start receiving ACTEMRA. If you have rheumatoid arthritis (RA), giant cell arteritis (GCA), or systemic sclerosis- interstitial lung disease (SSc-ILD) your healthcare provider should do blood tests every 4 to 8 weeks after you start receiving ACTEMRA for the first 6 month.
Tocilizumab (intravenous route, subcutaneous route ... - Mayo Clinic
Tocilizumab injection is also used alone or together with glucocorticoids (steroid medicine) to treat giant cell arteritis (inflammation of the arteries). It can be used alone after stopping treatment with glucocorticoids.
Actemra (Tocilizumab Injection): Side Effects, Uses, Dosage ... - RxList
2024年10月7日 · Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat moderate to severe rheumatoid arthritis in children and adults. What Are Side Effects of Actemra? Actemra may cause serious side effects including: Get medical help right away, if you have any of the symptoms listed above. Common side effects of Actemra include:
Tocilizumab - Wikipedia
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).